THYMOSIN ALPHA, 2000 MCG/ML, 5 ML vial, The Guyer Institute of Molecular Medicine, Indianapolis, IN
Published December 23, 2020 · Recall initiated: November 30, 2020
Summary
FDA records drug Class II recall D-0133-2021, published December 23, 2020 and initiated November 30, 2020. Recalling firm: Advanced Nutriceuticals, LLC; Status: Ongoing; Reported quantity: 4 vials; Lot: Lot #110220200, 1102202009, Exp 12/09/2020; Lot #1105202009, Exp 12/20/2020; Lot #1110202008, Exp 12/10/2020. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Advanced Nutriceuticals, LLC
- Distributor
- CA, CO, FL, IN, KY, OH, TX
- Lot
- Lot #110220200, 1102202009, Exp 12/09/2020; Lot #1105202009, Exp 12/20/2020; Lot #1110202008, Exp 12/10/2020
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAGHRP, 2000 MCG/ML, 5 ML vial, The Guyer Institute of Molecular Medicine, Indianapolis, INDecember 23, 2020
- FDALL-37, 2000 MCG/ML, 2 ML vial, The Guyer Institute of Molecular Medicine, Indianapolis, INDecember 23, 2020
- FDAAOD-9604, 1200 MCG/ML, 5 ML vial The Guyer Institute of Molecular Medicine, Indianapolis, INDecember 23, 2020
- FDABPC-157, 2000 MCG/ML, 5 ML vial, The Guyer Institute of Molecular Medicine, Indianapolis, INDecember 23, 2020
- FDAIPAMORELIN, 2000 MCG/ML, 5 ML vial, The Guyer Institute of Molecular Medicine, Indianapolis, INDecember 23, 2020
- FDAPT-141, 10 MG/ML, 2 ML vial, The Guyer Institute of Molecular Medicine, Indianapolis, INDecember 23, 2020
Questions about this recall
Was THYMOSIN ALPHA, 2000 MCG/ML, 5 ML vial, The Guyer Institute of Molecular Medicine, Indianapolis, IN recalled?
Yes. FDA published recall D-0133-2021 on December 23, 2020. Reported hazard: Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.
What should I do if I have this product?
Voluntary: Firm initiated · Letter